26,582 Shares in Corteva, Inc. $CTVA Acquired by Daiichi Life Insurance Co. Ltd.

Key Points

• Daiichi Life Insurance acquired 26,582 Corteva shares worth approximately $2.25 million in the second quarter, while institutional investors collectively own 81.54% of the company.
• Corteva reported quarterly EPS of $2.30, exceeding the $2.24 consensus estimate, though revenue fell 1.2% year over year to $6.38 billion. The company reaffirmed fiscal 2026 EPS guidance of $3.60–$3.80.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $91.50 versus the stock’s reported $81.84 price. Corteva also declared a quarterly dividend of $0.18 per share.

Daiichi Life Insurance Co. Ltd. purchased a new position in Corteva, Inc. (NYSE:CTVA - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 26,582 shares of the company's stock, valued at approximately $2,251,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CTVA. JPL Wealth Management LLC bought a new position in shares of Corteva in the third quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC bought a new stake in Corteva during the 4th quarter valued at $27,000. Bank of Jackson Hole Trust bought a new stake in Corteva during the 4th quarter valued at $28,000. Cornerstone Financial Management LLC purchased a new stake in Corteva during the 4th quarter valued at $29,000. Finally, Elevation Wealth Partners LLC grew its holdings in Corteva by 334.6% in the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company's stock worth $29,000 after acquiring an additional 261 shares during the last quarter. Institutional investors own 81.54% of the company's stock.

Corteva Trading Up 0.1%

NYSE:CTVA opened at $81.84 on Monday. The company has a 50-day moving average price of $82.13 and a 200-day moving average price of $80.26. The stock has a market cap of $54.60 billion, a price-to-earnings ratio of 54.20, a P/E/G ratio of 2.51 and a beta of 0.57. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97.

Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $6.38 billion for the quarter, compared to analysts' expectations of $6.60 billion. During the same quarter in the previous year, the company earned $2.20 earnings per share. Corteva's quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva's payout ratio is currently 47.68%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Citigroup increased their target price on shares of Corteva from $85.00 to $86.00 and gave the stock a "neutral" rating in a report on Monday, August 3rd. BMO Capital Markets upped their price target on Corteva from $95.00 to $100.00 and gave the company an "outperform" rating in a research report on Monday, August 3rd. Morgan Stanley increased their price objective on Corteva from $84.00 to $95.00 and gave the stock an "overweight" rating in a report on Thursday, May 28th. Bank of America lifted their price objective on Corteva from $90.00 to $96.00 and gave the stock a "buy" rating in a research report on Monday, July 20th. Finally, Weiss Ratings cut Corteva from a "hold (c+)" rating to a "hold (c)" rating in a research note on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $91.50.

Corteva Company Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source